Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis s a target, a substrate, and a regulator

Several ribosomal proteins regulate p53 function by modulating MDM2. We recently found that RPS27L, a RPS27-like protein, is a direct p53-inducible target. Here we showed that RPS27 itself is a p53-repressible target. Furthermore, the N-terminal region of either RPS27L or RPS27 binds to MDM2 on the central acidic domain of MDM2. RPS27L or RPS27 forms an in vivo triplex with MDM2-p53 and competes with p53 for MDM2 binding. Similar to p53, RPS27L, but not RPS27, is a short-lived protein and a novel MDM2 substrate. Degradation of RPS27L requires the RING or acidic domain of MDM2. Ectopic expression of RPS27L or RPS27 inhibits MDM-2-mediated p53 ubiquitination and increases p53 levels by extending p53 protein half-life, whereas siRNA silencing of RPS27L decreases p53 levels by shortening p53 half-life, with a corresponding reduction in p53 transcription activity. RPS27L is mainly localized in the cytoplasm, but upon p53-activating signals, a portion of RPS27L shuttled to the nucleoplasm where it colocalizes with MDM2. Both the cytoplasmic and the nuclear p53, induced by ribosomal stress, were reduced upon RPS27L silencing. Our study reveals a multilevel interplay between RPS27L/S27 and p53-MDM2 axis, with RPS27L functioning as a p53 target, a MDM2 substrate and a p53 regulator.

[1]  Fernandez-Pol Ja,et al.  Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy. , 1996 .

[2]  A. Levine,et al.  Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.

[3]  K. Itahana,et al.  Inhibition of HDM2 and Activation of p53 by Ribosomal Protein L23 , 2004, Molecular and Cellular Biology.

[4]  G. Semenza,et al.  SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1α ubiquitination and degradation , 2008, Oncogene.

[5]  K. Suzuki,et al.  Zinc finger-like motifs in rat ribosomal proteins S27 and S29. , 1993, Nucleic acids research.

[6]  X. Jacq,et al.  Ribosomal protein S7 is both a regulator and a substrate of MDM2. , 2009, Molecular cell.

[7]  P. Hamilton,et al.  Metallopanstimulin gene product produced in a baculovirus expression system is a nuclear phosphoprotein that binds to DNA. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[8]  D. Tollervey,et al.  Ribosome synthesis in Saccharomyces cerevisiae. , 1999, Annual review of genetics.

[9]  K. Bhat,et al.  Essential role of ribosomal protein L11 in mediating growth inhibition‐induced p53 activation , 2004, The EMBO journal.

[10]  M. Dai,et al.  Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition , 2004, Molecular and Cellular Biology.

[11]  H. He,et al.  Ribosomal protein S27L is a direct p53 target that regulates apoptosis , 2007, Oncogene.

[12]  C. Midgley,et al.  Mdm2 binding to a conformationally sensitive domain on p53 can be modulated by RNA , 2000, FEBS letters.

[13]  Patrick Linder,et al.  Protein trans-Acting Factors Involved in Ribosome Biogenesis in Saccharomyces cerevisiae , 1999, Molecular and Cellular Biology.

[14]  D. Ganger,et al.  Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia. , 2001, Cancer detection and prevention.

[15]  M. Kubbutat,et al.  Regulation of HDM2 activity by the ribosomal protein L11. , 2003, Cancer cell.

[16]  M. Dai,et al.  Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5* , 2004, Journal of Biological Chemistry.

[17]  J. Fletcher,et al.  Expression of metallopanstimulin and oncogenesis in human prostatic carcinoma. , 1997, Anticancer research.

[18]  Jiandong Chen,et al.  Rescue of mutant p53 transcription function by ellipticine , 2003, Oncogene.

[19]  P. Hamilton,et al.  A growth factor-inducible gene encodes a novel nuclear protein with zinc finger structure. , 1993, The Journal of biological chemistry.

[20]  C. Hollenbeak,et al.  Metallopanstimulin as a marker for head and neck cancer , 2004, World journal of surgical oncology.

[21]  Moshe Oren,et al.  Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. , 2008, Molecular cell.

[22]  D. Ganger,et al.  Metallopanstimulin is overexpressed in a patient with colonic carcinoma. , 1997, Anticancer research.

[23]  A. Levine,et al.  The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.

[24]  Yi Sun,et al.  SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation. , 2007, Cancer research.

[25]  T. Lawrence,et al.  Global Genechip Profiling to Identify Genes Responsive to p53-Induced Growth Arrest and Apoptosis in Human Lung Carcinoma Cells , 2003, Cancer biology & therapy.

[26]  J A Fernandez-Pol,et al.  Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy. , 1996, Anticancer research.

[27]  M. Soengas,et al.  ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence. , 2009, Cancer research.

[28]  Yanping Zhang,et al.  Putting a Finger on Growth Surveillance: Insight into MDM2 Zinc Finger-Ribosomal Protein Interactions , 2007, Cell cycle.

[29]  M. Hande,et al.  Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress. , 2007, Cancer research.

[30]  Yanping Zhang,et al.  Signaling to p53: ribosomal proteins find their way. , 2009, Cancer cell.

[31]  Y. Qu,et al.  In vitro and In vivo Evidence of Metallopanstimulin-1 in Gastric Cancer Progression and Tumorigenicity , 2006, Clinical Cancer Research.

[32]  C. Hollenbeak,et al.  A New Assay to Screen for Head and Neck Squamous cell Carcinoma Using the Tumor Marker Metallopanstimulin , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[33]  T. Allio,et al.  Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway , 2003, Molecular and Cellular Biology.

[34]  Shaomeng Wang,et al.  A small molecule that disrupts Mdm2-p53 binding activates p53, induces apoptosis, and sensitizes lung cancer cells to chemotherapy , 2008, Cancer biology & therapy.

[35]  C. Blattner,et al.  Binding of p53 to the Central Domain of Mdm2 Is Regulated by Phosphorylation* , 2006, Journal of Biological Chemistry.

[36]  A. Coulson,et al.  Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans , 2005, Nature.

[37]  T. Hupp,et al.  The Conformationally Flexible S9–S10 Linker Region in the Core Domain of p53 Contains a Novel MDM2 Binding Site Whose Mutation Increases Ubiquitination of p53 in Vivo * , 2002, The Journal of Biological Chemistry.

[38]  T. Ravikumar,et al.  Ubiquitin-ribosomal protein S27a gene overexpressed in human colorectal carcinoma is an early growth response gene. , 1993, Cancer research.

[39]  G. Semenza,et al.  SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1 alpha ubiquitination and degradation. , 2008, Oncogene.

[40]  Ronald W. Davis,et al.  Functional profiling of the Saccharomyces cerevisiae genome , 2002, Nature.

[41]  Dajun Yang,et al.  Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition , 2008, Proceedings of the National Academy of Sciences.

[42]  T. Sasajima,et al.  Identification of metallopanstimulin-1 as a member of a tumor associated antigen in patients with breast cancer. , 2002, Cancer letters.

[43]  M. Gerstein,et al.  Comparative analysis of processed ribosomal protein pseudogenes in four mammalian genomes , 2009, Genome Biology.

[44]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[45]  W. Wang,et al.  Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function , 2007, Oncogene.